EP1517702A4 - IMMUNOGENIC HBc CHIMER PARTICLES STABILIZED WITH AN N-TERMINAL CYSTEINE

110 sheets

Sheet 1
Sheet 2
Sheet 3
Sheet 4
Sheet 5
Sheet 6
Sheet 7
Sheet 8
Sheet 9
Sheet 10
Sheet 11
Sheet 12
Sheet 13
Sheet 14
Sheet 15
Sheet 16
Sheet 17
Sheet 18
Sheet 19
Sheet 20
Sheet 21
Sheet 22
Sheet 23
Sheet 24
Sheet 25
Sheet 26
Sheet 27
Sheet 28
Sheet 29
Sheet 30
Sheet 31
Sheet 32
Sheet 33
Sheet 34
Sheet 35
Sheet 36
Sheet 37
Sheet 38
Sheet 39
Sheet 40
Sheet 41
Sheet 42
Sheet 43
Sheet 44
Sheet 45
Sheet 46
Sheet 47
Sheet 48
Sheet 49
Sheet 50
Sheet 51
Sheet 52
Sheet 53
Sheet 54
Sheet 55
Sheet 56
Sheet 57
Sheet 58
Sheet 59
Sheet 60
Sheet 61
Sheet 62
Sheet 63
Sheet 64
Sheet 65
Sheet 66
Sheet 67
Sheet 68
Sheet 69
Sheet 70
Sheet 71
Sheet 72
Sheet 73
Sheet 74
Sheet 75
Sheet 76
Sheet 77
Sheet 78
Sheet 79
Sheet 80
Sheet 81
Sheet 82
Sheet 83
Sheet 84
Sheet 85
Sheet 86
Sheet 87
Sheet 88
Sheet 89
Sheet 90
Sheet 91
Sheet 92
Sheet 93
Sheet 94
Sheet 95
Sheet 96
Sheet 97
Sheet 98
Sheet 99
Sheet 100
Sheet 101
Sheet 102
Sheet 103
Sheet 104
Sheet 105
Sheet 106
Sheet 107
Sheet 108
Sheet 109
Sheet 110

Every citation, both waysCites: the store holds 6 of 7

Citations
Document	Relation	Office	Category	Cited during	Relevant claims
WO0214478A2	Cites	World Intellectual Property Organization (WIPO)	PX	Search report	1-78
WO9940934A1	Cites	World Intellectual Property Organization (WIPO)	Y	Search report	1-78
WO9957289A2	Cites	World Intellectual Property Organization (WIPO)	Y	Search report	1-78
WO9940934A	Cites	World Intellectual Property Organization (WIPO)	–	–	–
WO9957289A	Cites	World Intellectual Property Organization (WIPO)	–	–	–
WO0214478A	Cites	World Intellectual Property Organization (WIPO)	–	–	–
ULRICH R ET AL: "CORE PARTICLES OF HEPATITIS B VIRUS AS CARRIER FOR FOREIGN EPITOPES", ADVANCES IN VIRUS RESEARCH, SAN DIEGO, CA, US, vol. 50, 1998, pages 141 - 182, XP000856161	Non-patent	–	–	Search report	–
KRATZ P A ET AL: "NATIVE DISPLAY OF COMPLETE FOREIGN PROTEIN DOMAINS ON THE SURFACE OF HEPATITIS B VIRUS CAPSIDS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 96, 1999, pages 1915 - 1920, XP000910194, ISSN: 0027-8424	Non-patent	–	–	Search report	–
ZHOU S ET AL: "Cys residues of the hepatitis B virus capsid protein are not essential for the assembly of viral core particles but can influence their stability", JOURNAL OF VIROLOGY, NEW YORK, US, US, vol. 66, no. 9, September 1992 (1992-09-01), pages 5393 - 5398, XP002961917, ISSN: 0022-538X	Non-patent	–	–	Search report	–
SEIFER M ET AL: "Stability governs the apparent expression of particulate hepatitis e antigen by mutant hepatitis B virus core particles", VIROLOGY, ACADEMIC PRESS,ORLANDO, US, vol. 196, no. 1, September 1993 (1993-09-01), pages 70 - 78, XP002961918, ISSN: 0042-6822	Non-patent	–	–	Search report	–

121 members in 18 offices

This recordMember, by publication datePriority claim8 more offices are in the list below

Priority claims19

Priority claims
Document	Office	Kind	Date
80299	United States of America	–	2002-02-21
8029902	United States of America	A	2002-02-21
8029902	United States of America	A	2002-02-21
82014	United States of America	–	2002-02-21
8201402	United States of America	A	2002-02-21
8201402	United States of America	A	2002-02-21
274616	United States of America	–	2002-10-21
27461602	United States of America	A	2002-10-21
27461602	United States of America	A	2002-10-21
0305196	United States of America	W	2003-02-21
0305196	United States of America	W	2003-02-21
274616	–	–	–
80299	–	–	–
82014	–	–	–
US20020080299	–	–	–
US20020082014	–	–	–
US20020274616	–	–	–
US2003005196	–	–	–
WO2003US05196	–	–	–

Members121

Family members, oldest first
Document	Office	Kind
CA2420037A1	Canada	A1	2002-02-21
WO0214478A2	World Intellectual Property Organization (WIPO)	A2	2002-02-21
AU8545201A	Australia	A	2002-02-25
WO0214478A3	World Intellectual Property Organization (WIPO)	A3	2003-06-05
AP2003002752A0	African Regional Intellectual Property Organization (ARIPO)	A0	2003-06-30
US2003138769A1	United States of America	A1	2003-07-24
EP1333857A2	European Patent Office (EPO)	A2	2003-08-13
US2003175863A1	United States of America	A1	2003-09-18
US2003185858A1	United States of America	A1	2003-10-02
WO03081806A1	World Intellectual Property Organization (WIPO)	A1	2003-10-02
JP2003284128A	Japan	A	2003-10-03
US2003198645A1	United States of America	A1	2003-10-23
US2003202982A1	United States of America	A1	2003-10-30
KR20030084887A	Republic of Korea	A	2003-11-01
WO03102165A2	World Intellectual Property Organization (WIPO)	A2	2003-12-11
AU2003213168A1	Australia	A1	2003-12-19
AU2003213168A8	Australia	A8	2003-12-19
MXPA03001338A	Mexico	A	2004-01-26
EA200300270A1	Eurasian Patent Organization (EAPO)	A1	2004-04-29
CA2509484A1	Canada	A1	2004-06-24
WO2004053091A2	World Intellectual Property Organization (WIPO)	A2	2004-06-24
AU2003300841A1	Australia	A1	2004-06-30
US2004146524A1	United States of America	A1	2004-07-29
US2004152876A1	United States of America	A1	2004-08-05
US2004156863A1	United States of America	A1	2004-08-12
US2004156864A1	United States of America	A1	2004-08-12
AU2004216246A1	Australia	A1	2004-09-10
CA2516640A1	Canada	A1	2004-09-10
WO2004075836A2	World Intellectual Property Organization (WIPO)	A2	2004-09-10
WO2004075836A9	World Intellectual Property Organization (WIPO)	A9	2004-11-18
EP1489758A1	European Patent Office (EPO)	A1	2004-12-22
WO03102165A3	World Intellectual Property Organization (WIPO)	A3	2005-01-06
WO2004053091A3	World Intellectual Property Organization (WIPO)	A3	2005-03-10
EP1517702A2	European Patent Office (EPO)	A2	2005-03-30
JP2005517380A	Japan	A	2005-06-16
AU2004296886A1	Australia	A1	2005-06-23
CA2549104A1	Canada	A1	2005-06-23
WO2005055957A2	World Intellectual Property Organization (WIPO)	A2	2005-06-23
BR0113307A	Brazil	A	2005-06-28
ZA200301209B	South Africa	B	2005-06-29
CN1653725A	China	A	2005-08-10
US2005181831A1	United States of America	A1	2005-08-18
EP1572234A2	European Patent Office (EPO)	A2	2005-09-14
EA006207B1	Eurasian Patent Organization (EAPO)	B1	2005-10-27
KR20050103271A	Republic of Korea	A	2005-10-28
WO2005055957A3	World Intellectual Property Organization (WIPO)	A3	2005-11-03
EP1601327A2	European Patent Office (EPO)	A2	2005-12-07
BRPI0407632A	Brazil	A	2006-02-21
EP1333857A4	European Patent Office (EPO)	A4	2006-02-22
MXPA05008677A	Mexico	A	2006-02-22
JP2006509026A	Japan	A	2006-03-16
KR20060028384A	Republic of Korea	A	2006-03-29
EP1517702A4This record	European Patent Office (EPO)	A4	2006-05-03
OA12366A	African Intellectual Property Organization (OAPI)	A	2006-05-17
US2006115489A1	United States of America	A1	2006-06-01
NO20063157L	Norway	L	2006-09-11
WO2004075836A3	World Intellectual Property Organization (WIPO)	A3	2006-09-14
CN1838967A	China	A	2006-09-27
IL176051A0	Israel	A0	2006-10-05
EP1708748A2	European Patent Office (EPO)	A2	2006-10-11
EA200501330A1	Eurasian Patent Organization (EAPO)	A1	2006-10-27
AU2001285452B2	Australia	B2	2006-11-02
KR20070008535A	Republic of Korea	A	2007-01-17
US2007015199A1	United States of America	A1	2007-01-18
CN1913920A	China	A	2007-02-14
US2007036826A1	United States of America	A1	2007-02-15
ZA200507617B	South Africa	B	2007-02-28
MXPA06006185A	Mexico	A	2007-03-15
BRPI0417509A	Brazil	A	2007-05-08
JP2007513634A	Japan	A	2007-05-31
JP2007525421A	Japan	A	2007-09-06
CN101052414A	China	A	2007-10-10
CN101080239A	China	A	2007-11-28
EP1708748A4	European Patent Office (EPO)	A4	2008-03-19
AU2003300841B2	Australia	B2	2008-03-20
KR100815408B1	Republic of Korea	B1	2008-03-20
US7351413B2	United States of America	B2	2008-04-01
EP1601327A4	European Patent Office (EPO)	A4	2008-04-02
EP1572234A4	European Patent Office (EPO)	A4	2008-04-09
US7361352B2	United States of America	B2	2008-04-22
AU2004216246B2	Australia	B2	2008-08-07
NZ541702A	New Zealand	A	2008-08-29
AU2004296886B2	Australia	B2	2008-10-02
JP4166026B2	Japan	B2	2008-10-15
NZ540620A	New Zealand	A	2009-03-31
US7539461B2	United States of America	B2	2009-05-26
CN100508426C	China	C	2009-07-01
NZ547730A	New Zealand	A	2009-07-31
US2009239479A1	United States of America	A1	2009-09-24
CN101557252A	China	A	2009-10-14
EP1489758A4	European Patent Office (EPO)	A4	2010-04-14
CN1838967B	China	B	2010-05-26
US2010183652A1	United States of America	A1	2010-07-22
KR100991679B1	Republic of Korea	B1	2010-11-04
US7962103B2	United States of America	B2	2011-06-14
IL176051A	Israel	A	2011-06-30
US2011207416A1	United States of America	A1	2011-08-25
US8017127B2	United States of America	B2	2011-09-13
EP1572234B1	European Patent Office (EPO)	B1	2012-02-22
EP2425848A2	European Patent Office (EPO)	A2	2012-03-07

Showing 100 of 121

11 legal events, as the office reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code
2013-08-07	Application deemed to be withdrawnWithdrawn18D	18D
2013-07-05	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA	STAA
2009-12-30	First examination report despatched17Q	17Q
2006-05-03	Supplementary search report drawn up and despatchedA4	A4
2006-05-03	Information provided on ipc code assigned before grantRIC1	RIC1
2006-05-03	Information provided on ipc code assigned before grantRIC1	RIC1
2006-05-03	Information provided on ipc code assigned before grantRIC1	RIC1
2005-03-30	Request for examination filed17P	17P
2005-03-30	Designated contracting statesAK	AK
2005-03-30	Request for extension of the european patentAX	AX
2005-02-11	Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI	PUAI

Numbers

Publication: 1517702
Publication, DOCDB: 1517702
Publication, EPODOC: EP1517702
Application: 3709214
Application, DOCDB: 03709214
Application, EPODOC: EP20030709214

Titles3

German: MIT EINEM N-TERMINALEN CYSTEIN STABILISIERTE IMMUNOGENE HBc-CHIMÄRE-PARTIKEL
English: IMMUNOGENIC HBc CHIMER PARTICLES STABILIZED WITH AN N-TERMINAL CYSTEINE
French: PARTICULES CHIMERIQUES HBC IMMUNOGENES STABILISEES AVEC UNE CYSTEINE D'EXTREMITE N-TERMNALE

Classification

CPC, 15: C07K14/005
A61K39/015
A61K39/145
A61K2039/5258
A61K2039/57
C07K2319/00
C12N2730/10122
C12N2760/16134
A61K2039/543
A61K2039/55505
A61K2039/55566
A61K2039/55572
C12N2730/10134
A61K39/12
Y02A50/30
Filled: the office’s first classification
IPC, 6: C12Q1 70
A61K39 015
A61K39 145
A61K39 29
A61K39 385
C07K14 02

Designated states1

Contracting states, 1: Türkiye

IMMUNOGENIC HBc CHIMER PARTICLES STABILIZED WITH AN N-TERMINAL CYSTEINE

Abstract

Term